2.22

10.00% 0.22

Mereo Biopharma Group Plc Adr (MREO)

Overview News Price History Option Chain Discussions Forecast

Mereo Biopharma Group Plc Adr stock is traded at $2.22, with a volume of 1.17M. It is up +10.00% in the last 24 hours and up +22.22% over the past month. Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).

Previous Close:

$2.00

Open:

$2.09

24h Volume:

1.17M

Relative Volume:

0.68

Market Cap:

$353.27M

Revenue:

$10.00M

Net Income/Loss:

$-29.47M

P/E Ratio:

-11.10

EPS:

-0.2

Net Cash Flow:

$-21.55M

1W Performance:

+0.46%

1M Performance:

+22.22%

6M Performance:

-22.81%

1Y Performance:

-34.33%

1-Day Range:

$2.07

$2.22

1-Week Range:

$1.885

$2.195

52-Week Range:

$1.47

$3.88

Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile

Name

Mereo Biopharma Group Plc Adr

Sector

Healthcare (1135)

Industry

Biotechnology (633)

Phone

4403330237300

Address

ONE CAVENDISH PLACE, LONDON

Employee

Twitter

@MereoBioPharma

Next Earnings Date

2025-03-26

Latest SEC Filings

MREO's Discussions on Twitter

Compare MREO with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
MREO Mereo Biopharma Group Plc Adr	2.22	318.26M	10.00M	-29.47M	-21.55M	-0.20
VRTX Vertex Pharmaceuticals Inc	458.61	115.75B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	780.00	80.71B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	410.52	52.88B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	854.63	52.64B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	177.99	37.29B	447.02M	-1.18B	-906.14M	-6.1812

Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-27-25	Initiated	JP Morgan	Overweight
Dec-06-24	Initiated	Jefferies	Buy
Jun-13-24	Initiated	Robert W. Baird	Outperform
Oct-13-23	Resumed	BTIG Research	Buy
Aug-12-22	Initiated	Cantor Fitzgerald	Overweight
May-05-21	Initiated	BTIG Research	Buy
Apr-05-21	Initiated	Needham	Buy

View All

Mereo Biopharma Group Plc Adr Stock (MREO) Latest News

Dec 19, 2025

Mereo BioPharma Group’s (MREO) “Buy” Rating Reaffirmed at BTIG Research - Defense World

Dec 19, 2025

Dec 16, 2025

Mereo BioPharma Group plcSponsored ADR (NASDAQ:MREO) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat

Dec 16, 2025

Dec 14, 2025

683 Capital Management LLC Decreases Stock Holdings in Mereo BioPharma Group plc – Sponsored ADR $MREO - Defense World

Dec 14, 2025

Dec 12, 2025

Traders Purchase High Volume of Put Options on Mereo BioPharma Group (NASDAQ:MREO) - Defense World

Dec 12, 2025

Dec 11, 2025

Mereo BioPharma Group Target of Unusually Large Options Trading (NASDAQ:MREO) - MarketBeat

Dec 11, 2025

Investors Buy High Volume of Call Options on Mereo BioPharma Group (NASDAQ:MREO) - Defense World

Dec 11, 2025

Dec 10, 2025

Mereo BioPharma Group Target of Unusually High Options Trading (NASDAQ:MREO) - MarketBeat

Dec 10, 2025

It makes sense and dollars to buy Mereo Biopharma Group Plc ADR (MREO) stock - setenews.com

Dec 10, 2025

Dec 05, 2025

Baird names Mereo BioPharma stock a Fresh Pick ahead of OI data - Investing.com UK

Dec 05, 2025

Dec 03, 2025

This trade activity should not be overlooked: Mereo Biopharma Group Plc ADR (MREO) - Setenews

Dec 03, 2025

Dec 01, 2025

Mereo BioPharma Group plc (MREO) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade

Dec 01, 2025

Nov 27, 2025

Cantor Fitzgerald Analysts Raise Earnings Estimates for MREO - MarketBeat

Nov 27, 2025

Equities Analysts Issue Forecasts for MREO FY2025 Earnings - Defense World

Nov 27, 2025

Nov 26, 2025

A better buy-in window may exist right now for Mereo Biopharma Group Plc ADR (MREO) - Setenews

Nov 26, 2025

Nov 21, 2025

Mereo BioPharma Group plc – Sponsored ADR (NASDAQ:MREO) Receives Consensus Rating of “Moderate Buy” from Brokerages - Defense World

Nov 21, 2025

Nov 19, 2025

Wall Street analysts’ outlook for Mereo Biopharma Group Plc ADR (MREO) - Setenews

Nov 19, 2025

Nov 14, 2025

A new trading data show Mereo Biopharma Group Plc ADR (MREO) is showing positive returns. - setenews.com

Nov 12, 2025

Nov 10, 2025

[8-K] Mereo BioPharma Group plc Reports Material Event | MREO SEC FilingForm 8-K - Stock Titan

Nov 10, 2025

Nov 05, 2025